How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development
This review examines the molecular characteristics of the uterine endometrium, endometriosis, and associated ovarian cancers, discussing the genomic alterations that may drive cancer development from the endometrium through endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (89)
- ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis via openalex
- BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer via openalex
- Biological significance of <i>KRAS</i> mutant allele expression in ovarian endometriosis via openalex
- Cancer-Associated Mutations in Endometriosis without Cancer via openalex
- Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium via openalex
- Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis via openalex
- Coelomic Metaplasia Theory of Endometriosis: Evidence from in vivo Studies and an in vitro Experimental Model via openalex
- Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts via openalex
- Endometriosis: benign, malignant, or something in between? via openalex
- <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas via openalex
- Iatrogenic endometriosis harbors somatic cancer-driver mutations via openalex
- <i>PIK3CA</i> mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinoma via openalex
- Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma via openalex
- Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. via openalex
- Measuring health-related quality of life in women with endometriosis: comparing the clinimetric properties of the Endometriosis Health Profile-5 (EHP-5) and the EuroQol-5D (EQ-5D) via openalex
- Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. via openalex
- Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis via openalex
- Molecular genetic evidence that endometriosis is a precursor of ovarian cancer via openalex
- Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors via openalex
- Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden via openalex
- Oncogenic mutations in histologically normal endometrium: the new normal? via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- The association between endometriosis and gynecological cancers and breast cancer: A review of epidemiological data via openalex
- The <i>ARID1A</i> pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis via openalex
- The Origin and Pathogenesis of Endometriosis via openalex
- The role of iron in the pathogenesis of endometriosis via openalex
- W2169312351 via openalex
- W2174510671 via openalex
- W2206969062 via openalex
- W2223921723 via openalex
- W2282447757 via openalex
- W2608835133 via openalex
- W2736756678 via openalex
- W2744601229 via openalex
- W2748335901 via openalex
- W2753398988 via openalex
- W2775281868 via openalex
- W2782365191 via openalex
- W2782426754 via openalex
- W2810127666 via openalex
- W2891585088 via openalex
- W2905667684 via openalex
- W2929496863 via openalex
- W2948037491 via openalex
- W2963040485 via openalex
- W2963202264 via openalex
- W2964615569 via openalex
- W2981552021 via openalex
- W2990717414 via openalex
- W3009319701 via openalex
- W3014242925 via openalex
- W3020114628 via openalex
- W3020771563 via openalex
- W3036702906 via openalex
- W3087700560 via openalex
- W3089590915 via openalex
- W3091045317 via openalex
- W3091480325 via openalex
- W3103463999 via openalex
- W3104388341 via openalex
- W3110112774 via openalex
- W4250939868 via openalex
- W6638686170 via openalex
- W6684518720 via openalex
- W1608765630 via openalex
- W1956871134 via openalex
- W1963853602 via openalex
- W1973837499 via openalex
- W1975836293 via openalex
- W1975913714 via openalex
- W1978088642 via openalex
- W1983416548 via openalex
- W2013368246 via openalex
- W2016661249 via openalex
- W2031238872 via openalex
- W2041440766 via openalex
- W2054097842 via openalex
- W2063382154 via openalex
- W2067117191 via openalex
- W2075191363 via openalex
- W2077858999 via openalex
- W2086830762 via openalex
- W2087999409 via openalex
- W2103540939 via openalex
- W2125681453 via openalex
- W2158335713 via openalex
- W2161661150 via openalex
- W2163476499 via openalex
- W2164995160 via openalex
Cited by (26)
- From Gene Networks to Repurposed Drugs: A Systems Biomedicine Approach to Endometriosis Management 2026
- Spatiotemporal Evolutionary Mechanisms and Translational Research Progress in the Malignant Transformation of Endometriosis: A Comprehensive Review 2026
- Ovarian Cancer and Its Association with Endometriosis: A Narrative Review 2025
- Patients’ knowledge, attitudes, and practices concerning endometriosis and its long-term management 2025
- Evaluation of Genes and Molecular Pathways Involved in the Switch of Endometriosis to Ovarian Cancer: A Systems Biology Approach 2025
- Altered Apoptosis in Endometriosis Compared with Ovarian Carcinoma 2025
- Alterations in lipid metabolism in ovarian endometriosis and combined ovarian cancer revealed by untargeted lipidomics 2025
- Role of small extracellular-vesicle microRNA-302f in endometriosis-associated ovarian cancer 2025
- Iron overload increases the sensitivity of endometriosis stromal cells to ferroptosis via a PRC2-independent function of EZH2 2024
- Endometriosis as a risk factor for ovarian cancer: an update on screening, risk reduction, treatment and prognosis 2024
- Endometriosis-Associated Ovarian Carcinoma 2024
- Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma 2024
- The “Road” to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review 2024
- Immune Checkpoints in Endometriosis—A New Insight in the Pathogenesis 2024
- Role of the gut microbiota in the pathogenesis of endometriosis: a review 2024
- Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis 2023
- miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer—Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer 2023
- Pathogenesis of endometrium‐related diseases based on genomic alterations in normal uterine endometrium 2023
- Differences in the position of endometriosis-associated and non-associated ovarian cancer relative to the uterus 2023
- Endometrial epithelial cells-derived exosomes deliver microRNA-30c to block the BCL9/Wnt/CD44 signaling and inhibit cell invasion and migration in ovarian endometriosis 2022
- KRAS Mutation in Endometriosis-Associated Ovarian Borderline and Malignant Epithelial Tumors 2022
- Potential mechanism of four agents decoction in the treatment of endometriosis based on network pharmacology and molecular docking 2022
- Research Progress on Malignant Transformation of Ovarian Endometriosis and Wnt Signal Pathways in This Process 2022
- Placenta Previa Complicated with Endometriosis: Contemporary Clinical Management, Molecular Mechanisms, and Future Research Opportunities 2021
- Mesenchymal Stromal Cells Isolated from Ectopic but Not Eutopic Endometrium Display Pronounced Immunomodulatory Activity In Vitro 2021
- Screening differentially expressed genes between endometriosis and ovarian cancer to find new biomarkers for endometriosis 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:43.494969+00:00